[go: up one dir, main page]

HRP20090677T1 - Derivati 5-piridinil-1-azabiciklo[3.2.1]oktana, postupak njihovog dobivanja i njihova upotreba kao terapijskih sredstava - Google Patents

Derivati 5-piridinil-1-azabiciklo[3.2.1]oktana, postupak njihovog dobivanja i njihova upotreba kao terapijskih sredstava Download PDF

Info

Publication number
HRP20090677T1
HRP20090677T1 HR20090677T HRP20090677T HRP20090677T1 HR P20090677 T1 HRP20090677 T1 HR P20090677T1 HR 20090677 T HR20090677 T HR 20090677T HR P20090677 T HRP20090677 T HR P20090677T HR P20090677 T1 HRP20090677 T1 HR P20090677T1
Authority
HR
Croatia
Prior art keywords
azabicyclo
pyrid
octane
compound
formula
Prior art date
Application number
HR20090677T
Other languages
English (en)
Croatian (hr)
Inventor
Galli Fr�d�ric
Leclerc Odile
Lochead Alistair
Vache Julien
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36273387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090677(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of HRP20090677T1 publication Critical patent/HRP20090677T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR20090677T 2005-08-12 2006-08-07 Derivati 5-piridinil-1-azabiciklo[3.2.1]oktana, postupak njihovog dobivanja i njihova upotreba kao terapijskih sredstava HRP20090677T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0508528A FR2889701B1 (fr) 2005-08-12 2005-08-12 Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
PCT/FR2006/001912 WO2007020344A1 (fr) 2005-08-12 2006-08-07 DÉRIVÉS DE δ-PYRIDINYL-i-AZABICYCLO[3.2.1]OCTANE, A LEUR PRÉPARATION ET LEUR APPLICATION EN THÉRAPEUTIQUE

Publications (1)

Publication Number Publication Date
HRP20090677T1 true HRP20090677T1 (hr) 2010-01-31

Family

ID=36273387

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090677T HRP20090677T1 (hr) 2005-08-12 2006-08-07 Derivati 5-piridinil-1-azabiciklo[3.2.1]oktana, postupak njihovog dobivanja i njihova upotreba kao terapijskih sredstava

Country Status (40)

Country Link
US (2) US7863290B2 (sl)
EP (1) EP1915375B1 (sl)
JP (1) JP5164841B2 (sl)
KR (1) KR101299339B1 (sl)
CN (1) CN101238125B (sl)
AT (1) ATE444964T1 (sl)
AU (1) AU2006281341B2 (sl)
BR (1) BRPI0614623A2 (sl)
CA (1) CA2617828C (sl)
CR (1) CR9625A (sl)
CY (1) CY1109717T1 (sl)
DE (1) DE602006009668D1 (sl)
DK (1) DK1915375T3 (sl)
DO (1) DOP2006000180A (sl)
EA (1) EA014023B1 (sl)
EC (1) ECSP088170A (sl)
ES (1) ES2332472T3 (sl)
FR (1) FR2889701B1 (sl)
GT (1) GT200600368A (sl)
HN (1) HN2008000090A (sl)
HR (1) HRP20090677T1 (sl)
IL (1) IL188796A (sl)
JO (1) JO2583B1 (sl)
MA (1) MA30200B1 (sl)
ME (1) ME01750B (sl)
MX (1) MX2008001968A (sl)
MY (1) MY147846A (sl)
NO (1) NO20081151L (sl)
NZ (1) NZ565149A (sl)
PE (1) PE20070339A1 (sl)
PL (1) PL1915375T3 (sl)
PT (1) PT1915375E (sl)
RS (1) RS51068B (sl)
SI (1) SI1915375T1 (sl)
TN (1) TNSN07472A1 (sl)
TW (1) TWI324158B (sl)
UA (1) UA92917C2 (sl)
UY (1) UY29744A1 (sl)
WO (1) WO2007020344A1 (sl)
ZA (1) ZA200800958B (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912404B1 (fr) * 2007-02-09 2009-04-10 Sanofi Aventis Sa Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
GB0817424D0 (en) 2008-09-24 2008-10-29 Medivir Ab Protease inhibitors
JP2017114765A (ja) * 2014-04-25 2017-06-29 大正製薬株式会社 トリアゾリルで置換されたヘテロアリール化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
EP0664293A1 (en) * 1993-12-24 1995-07-26 Duphar International Research B.V 2-Phenyl-7-azabicycloheptanes and 6-phenyl-8-azabicyclo
CN1157392C (zh) * 1997-05-30 2004-07-14 神经研究公司 在尼古丁ach受体上作为胆碱能配体的8-氮杂双环(3,2,1)辛-2-烯以及辛烷衍生物
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
AU2006281341A1 (en) 2007-02-22
HN2008000090A (es) 2010-08-19
EP1915375A1 (fr) 2008-04-30
PE20070339A1 (es) 2007-04-18
EA200800575A1 (ru) 2008-06-30
GT200600368A (es) 2007-07-06
MY147846A (en) 2013-01-31
EA014023B1 (ru) 2010-08-30
US7863290B2 (en) 2011-01-04
ES2332472T3 (es) 2010-02-05
NZ565149A (en) 2011-05-27
JO2583B1 (en) 2011-02-27
CN101238125A (zh) 2008-08-06
UY29744A1 (es) 2007-03-30
JP5164841B2 (ja) 2013-03-21
RS51068B (sr) 2010-10-31
ZA200800958B (en) 2009-04-29
IL188796A0 (en) 2008-08-07
CN101238125B (zh) 2012-07-04
EP1915375B1 (fr) 2009-10-07
FR2889701A1 (fr) 2007-02-16
IL188796A (en) 2012-09-24
DOP2006000180A (es) 2007-02-28
AU2006281341B2 (en) 2012-04-19
PT1915375E (pt) 2009-11-26
NO20081151L (no) 2008-05-13
TNSN07472A1 (en) 2009-03-17
US20080146608A1 (en) 2008-06-19
KR20080033378A (ko) 2008-04-16
JP2009505971A (ja) 2009-02-12
CR9625A (es) 2008-04-10
MA30200B1 (fr) 2009-02-02
WO2007020344A1 (fr) 2007-02-22
ATE444964T1 (de) 2009-10-15
CA2617828A1 (fr) 2007-02-22
US20110077264A1 (en) 2011-03-31
FR2889701B1 (fr) 2007-10-05
SI1915375T1 (sl) 2010-01-29
DK1915375T3 (da) 2010-02-15
CY1109717T1 (el) 2014-08-13
ECSP088170A (es) 2008-03-26
KR101299339B1 (ko) 2013-08-26
MX2008001968A (es) 2008-03-26
UA92917C2 (uk) 2010-12-27
TW200740810A (en) 2007-11-01
HK1120788A1 (en) 2009-04-09
PL1915375T3 (pl) 2010-03-31
DE602006009668D1 (de) 2009-11-19
BRPI0614623A2 (pt) 2011-04-12
ME01750B (me) 2010-10-31
TWI324158B (en) 2010-05-01
CA2617828C (fr) 2014-03-11
US8541440B2 (en) 2013-09-24

Similar Documents

Publication Publication Date Title
JP5719773B2 (ja) 末梢オピオイド受容体アンタゴニストおよびその使用
CA3121719A1 (en) Amino-acid anilides as small molecule modulators of il-17
US20090181998A1 (en) Opioid receptor subtype-selective agents
UA120571C2 (uk) Алостеричні модулятори нікотинових ацетилхолінових рецепторів
WO2008064318A2 (en) Peripheral opioid receptor active compounds
JP2014500319A (ja) ファルネソイドｘ受容体を調節するための組成物および方法
CN118843624A (zh) 结晶的咪唑并[4,5-b]吡啶化合物、药物组合物以及它们在治疗医学病况中的应用
JP2006519208A (ja) 新規ジアザビシクロアリール誘導体
HRP20090677T1 (hr) Derivati 5-piridinil-1-azabiciklo[3.2.1]oktana, postupak njihovog dobivanja i njihova upotreba kao terapijskih sredstava
JP2021506916A (ja) Ｋｅａｐ１のＢＴＢドメインの小分子モジュレータ
JP2022504988A (ja) Ｌｒｒｋ２の野生型および変異型のアザインドール阻害剤
WO2004033456A2 (fr) Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique ayant trait au dysfonctionnement des recepteurs nicotiniques
EP0869956A1 (en) Pharmaceutical compositions
CN111107846A (zh) 烟碱乙酰胆碱受体的杂芳基变构调节剂
EP2765858B1 (en) Mineralocorticoid receptor antagonists
HRP20110043T1 (hr) Derivati 5-piridazinil-1-azabiciklo[3.2.1]oktana, njihovo dobivanje i njihova upotreba u terapiji
JP2024012450A (ja) 受容体阻害剤、同阻害剤を含む医薬組成物及びその使用
KR20230172529A (ko) 무스칼린 작용제 약물과 접합된 알파2 아드레날린 작용제 복합 약물
JP2005536522A (ja) ジアザビシクロノナン及び−デカン誘導体並びにこれをオピオイドレセプターリガンドとして使用する方法
TWI715156B (zh) 苯并咪唑化合物及其用於治療阿茲海默症或亨丁頓氏症之用途
TW201412736A (zh) 二氮呯酮衍生物
JP2000506871A (ja) 複素環式化合物並びにその調製及び用途
US9938249B2 (en) Anti-amyloid compounds containing benzofurazan